Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol vs Ondansetron for Nausea and Vomiting in the ED
NCT04764344Phase 4Completed
- Sponsor
- Western Michigan University Homer Stryker M.D. School of Medicine
- Start
- Apr 2021
- Primary completion
- May 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of haloperidol in nausea ((none)) and Vomiting (2 arms), sponsored by Western Michigan University Homer Stryker M.D. School of Medicine. Primary endpoint: Visual Analog Scale for Nausea. Started Apr 2021; status: completed.
02
Drugs
haloperidol
03
Conditions
nausea ((none))Vomiting
Beyond the preview
Go deeper on NCT04764344.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04764344.